Skip to Content

Join the 'Entresto' group to help and get support from people like you.

Entresto News

FDA Finds Another Carcinogen in Certain Valsartan Heart Meds

Posted 14 Sep 2018 by Drugs.com

FRIDAY, Sept. 14, 2018 – There's more bad news for Americans who took certain brands of the common blood pressure medication valsartan. The U.S. Food and Drug Administration on Thursday warned that it has found a second impurity in three lots of Torrent Pharmaceuticals' valsartan drug products, which are used to treat both high blood pressure and heart failure. The FDA first recalled valsartan ...

No Short-Term Cancer Risk From Recalled Heart Med Valsartan: Study

Posted 13 Sep 2018 by Drugs.com

THURSDAY, Sept. 13, 2018 – People who took recalled blood pressure drugs containing a carcinogen do not appear to have a markedly increased short-term risk of cancer, a new study reports. Doctors are reluctant to say they're fully in the clear, however. The U.S. Food and Drug Administration in July recalled valsartan medicines manufactured by the Chinese company Zhejiang Huahai Pharmaceuticals. ...

Affected by the Valsartan Heart Drug Recall? Here's What to Do

Posted 19 Jul 2018 by Drugs.com

THURSDAY, July 19, 2018 – After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what's next for their cardiovascular care. The FDA said it mandated the recall because valsartan medicines from a Chinese manufacturer, Zhejiang Huahai Pharmaceuticals, were found to ...

Know Your Heart's Numbers

Posted 7 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – More than two-thirds of Americans fret about heart disease, but few know the specific information that can help them boost their heart health, a new survey finds. "Studies have suggested the majority of coronary artery disease events can be prevented by addressing treatable risk factors," said Dr. Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic. ...

Statins Often Interact With Other Heart Drugs

Posted 17 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Cholesterol-lowering statins can interact with other drugs prescribed for heart disease. But there are ways to navigate the problem, according to new recommendations from the American Heart Association. Statins are among the mostly widely prescribed drugs in the United States. Roughly one-quarter of Americans age 40 and up are on a statin, according to a 2014 study by the ...

Updated Heart Failure Treatment Guidelines Issued

Posted 21 May 2016 by Drugs.com

FRIDAY, May 20, 2016 – An updated guideline adds two new types of drugs to the list of treatment options for heart failure. In people with the condition, the heart can't pump enough blood throughout the body. The two new treatments in the updated guidelines are an angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril), sold as Entresto, and a sinoatrial node modulator (ivabradine), ...

New Drug May Help Fight Heart Failure

Posted 2 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 2, 2015 – Millions of aging Americans suffer from heart failure, and there are still too few options to treat them. Now, research suggests that a new medication called Entresto might help these patients live longer. The study did not involve a clinical trial. Instead, researchers analyzed data from nearly 8,400 heart failure patients with reduced ejection fraction, where a ...

FDA Approves New Drug Entresto for Heart Failure

Posted 10 Jul 2015 by Drugs.com

THURSDAY, July 9, 2015 – The U.S. Food and Drug Administration has approved the first in a new class of drugs that show promise for combating heart failure. The approval of Entresto (sacubitril/varsatan) was sped up after a clinical trial found it significantly reduced the rate of death and hospitalization due to heart failure compared to another, often-prescribed treatment, the FDA said in a ...

Entresto Approved for Heart Failure

Posted 8 Jul 2015 by Drugs.com

TUESDAY, July 7, 2015 – The U.S. Food and Drug Administration on Tuesday approved the drug Entresto (sacubitril/valsartan) to treat heart failure. Characterized by the heart's inability to pump enough blood, the progressive disease affects some 5.1 million people in the United States. Heart attack, high blood pressure and other conditions that damage the heart are primary causes, the agency said ...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

Posted 7 Jul 2015 by Drugs.com

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure. Heart failure is a common condition affecting about 5.1 million people in the United States. It is a condition in which the heart can't pump ...

Ask a Question

Further Information

Related Condition Support Groups

Heart Failure, Congestive Heart Failure

Entresto Patient Information at Drugs.com